Pålsson A
Acta Psychiatr Scand Suppl. 1986;329:140-5. doi: 10.1111/j.1600-0447.1986.tb10551.x.
A clinical analysis of 476 cases of delirium tremens is presented. The sample covers virtually all cases of delirium tremens that occurred in the Helsingborg Health Service District during the period 1975-1980. A retrospective analysis of the incidence of delirium tremens over the observation period shows that there was an increase in the number and severity of cases developing delirium tremens when non-cross-tolerant drugs, such as carbamazepine and neuroleptics, were used as first-line treatment for acute alcohol withdrawal. The results also show that when chlormethiazole (a drug exhibiting a certain degree of cross-tolerance with ethanol) was used either as the first-line treatment for all cases or as the first-line treatment for predetermined "high risk" patients, the incidence of delirium tremens was greatly reduced. The favourable findings when chlormethiazole treatment was initiated at an early stage in the "high risk" patients suggest that chlormethiazole has a protective action against delirium tremens. Moreover, in the occasional case in which delirium tremens occurred during chlormethiazole treatment, the disorder was milder and relatively easy to treat.
本文对476例震颤谵妄患者进行了临床分析。该样本涵盖了1975年至1980年期间在赫尔辛堡卫生服务区发生的几乎所有震颤谵妄病例。对观察期内震颤谵妄发病率的回顾性分析表明,当使用卡马西平和抗精神病药等非交叉耐受性药物作为急性酒精戒断的一线治疗药物时,发生震颤谵妄的病例数量和严重程度均有所增加。结果还表明,当氯美噻唑(一种与乙醇表现出一定程度交叉耐受性的药物)用作所有病例的一线治疗药物或用作预定“高危”患者的一线治疗药物时,震颤谵妄的发病率大大降低。在“高危”患者中早期开始使用氯美噻唑治疗时的良好结果表明,氯美噻唑对震颤谵妄具有保护作用。此外,在氯美噻唑治疗期间偶尔发生震颤谵妄的病例中,病情较轻且相对易于治疗。